Should Pink October Turn Blue?

By Chris Adams, Research Advocate for Fight Colorectal Cancer Last month, you may have noticed the pink jetliners, pink NFL players and pink garbage trucks.  Yes, it was Pink October, also known as National Breast Cancer Awareness Month (NBCAM).  NBCAM is probably the biggest and most successful public awareness campaign in modern US history.  NBCAM’s goal…  Read More

FDA Avastin Breast Cancer Decision Doesn't Impact Colorectal Cancer Treatment

Although FDA Commissioner Margaret Hamburg announced a final decision on November 18 to drop breast cancer from the Avastin label, metastatic colorectal cancer continues to be an approved use. The Avastin® (bevacizumab) label includes the following approved indication: Metastatic colorectal cancer, with intravenous 5-fluorouracil–based chemotherapy for first- or second-line treatment. It is important to know that…  Read More

Is Breast Cancer Linked to Lynch Syndrome?

Although breast cancer has not traditionally been considered one of the cancers associated with Lynch syndrome, evidence is building that there might be a link. Breast cancer may actually be with in the spectrum of Lynch cancers. An Australian team reviewing the pathology of breast cancers in women who carried a mutation for Lynch syndrome (…  Read More